Metabolic Diseases: Cellular and Molecular Mechanisms: A Point of View
International Journal of Biomedicine · 10.06.2026 · 16 (2)
DOI: 10.21103/article16(2)_pv ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedicine, online erschienen am 05.06.2026.
Abstract (Originalsprache)
The Developmental Origins of Health and Disease (DOHaD) framework highlights that unfavorable conditions during fetal development can trigger persistent biological changes, increasing the risk of metabolic disorders in adulthood.While clinical manifestations often appear only later in life, fetal programming produces subtle but permanent structural, functional, and epigenetic modifications in key metabolic organs-including the pancreas, liver, and skeletal muscle.These early alterations weaken physiological resilience and predispose tissues to dysfunction when exposed to postnatal challenges such as poor diet, sedentary behavior, chronic stress, or environmental toxins.Initially, compensatory mechanisms may mask these vulnerabilities, but with aging and cumulative metabolic stress, these reserves decline, culminating in overt conditions such as hypertension, obesity, type 2 diabetes, and vascular disease.Cellular and molecular mechanisms-including epigenetic remodeling, disrupted signaling pathways, mitochondrial impairment, and chronic low-grade inflammation-serve as mediators linking early-life insults to long-term metabolic dysregulation.Because individuals with normal birth weight also develop these disorders with advancing age, it is plausible that such disease clusters have an age-related component.Downstream consequences of metabolic dysfunctionsuch as oxidative stress, impaired vascular tone, endothelial dysfunction, dysregulated glucose and lipid metabolism, arterial narrowing, and activation of platelet and coagulation pathways-further drive the progression of metabolic risk.By dissecting these mechanisms, it becomes possible to identify early biomarkers and design targeted interventions that halt disease progression before irreversible damage sets in.Thus, integrating developmental biology with molecular medicine offers a powerful opportunity to prevent and treat metabolic disorders rooted in early life.However, contemporary medical practice remains largely diseasefocused, emphasizing management of established risk factors.A more forward-looking approach must prioritize early detection, preventive strategies, and lifestyle modification, guided by a deep understanding of the cellular and molecular foundations of metabolic vulnerability.(
Zitieren
APA
(2026). Metabolic Diseases: Cellular and Molecular Mechanisms: A Point of View. International Journal of Biomedicine, 16(2). https://doi.org/10.21103/article16(2)_pv
Vancouver
Metabolic Diseases: Cellular and Molecular Mechanisms: A Point of View. International Journal of Biomedicine. 2026;16(2). doi:10.21103/article16(2)_pv
BibTeX
@article{euvimed2026,
title = {Metabolic Diseases: Cellular and Molecular Mechanisms: A Point of View},
journal = {International Journal of Biomedicine},
year = {2026},
volume = {16},
number = {2},
doi = {10.21103/article16(2)_pv}
}
EUVIMED